Connection

Julian Schulze Zur Wiesch to Young Adult

Back to Details
This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about Young Adult.
Julian Schulze Zur Wiesch
Connection Strength
0.063
Young Adult
  1. Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients. Medicine (Baltimore). 2019 Aug; 98(32):e16721.
    View in: PubMed
    Score: 0.022
  2. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):345-349.
    View in: PubMed
    Score: 0.020
  3. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients. J Clin Virol. 2020 09; 130:104549.
    View in: PubMed
    Score: 0.006
  4. Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center. Infection. 2018 Dec; 46(6):847-853.
    View in: PubMed
    Score: 0.005
  5. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. J Hepatol. 2018 07; 69(1):36-42.
    View in: PubMed
    Score: 0.005
  6. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). Clin Infect Dis. 2016 11 15; 63(10):1320-1324.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.